TSPAN6 and colorectal carcinoma: We have selected four candidates (TACSTD2/TROP2, TM9SF2, TSPAN6, and NGFR) and preliminarily verified their overexpression at protein levels in 30 CRC patients' tissue samples by immunohistochemistry [25].